Perflubutane

Key facts

Active substance
Perflubutane
Therapeutic area
Cardiovascular diseases
Decision number
P/106/2008
PIP number
Perflubutane
Pharmaceutical form(s)
Lyophilisate for suspension for injection
Condition(s) / indication(s)
Visualisation of myocardial perfusion for diagnostic purposes
Route(s) of administration
Intravenous use
Contact for public enquiries
Applicant: Nycomed Danmark ApS
E-mail: kristina.allikmets@nycomed.com
Country: Denmark
Phone: +45 46771655
Fax: +45 46756031
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating